Soleno Therapeutics, Inc.
SLNO
$33.39
-$0.37-1.08%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -38.78% | 73.94% | -1.07% | -0.51% | 13.50% |
| Total Receivables | 10.59% | 3.58% | -- | -- | -- |
| Inventory | 125.11% | 183.40% | -- | -- | -- |
| Prepaid Expenses | 90.16% | 25.93% | -49.38% | 139.19% | 72.31% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -33.47% | 68.84% | 2.55% | 5.11% | 13.82% |
|
|
|||||
| Total Current Assets | -33.47% | 68.84% | 2.55% | 5.11% | 13.82% |
| Net Property, Plant & Equipment | -3.57% | -5.23% | -6.34% | -6.97% | -6.40% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -9.09% | -8.32% | -7.69% | -7.16% | -6.67% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 96.39% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Assets | -6.01% | 80.52% | 4.47% | -3.89% | 11.55% |
|
|
|||||
| Total Accounts Payable | 52.67% | 31.03% | 13.37% | -38.27% | 42.27% |
| Total Accrued Expenses | 14.47% | 184.62% | 30.89% | -30.14% | 80.64% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.16% | 3.11% | 13.23% | 13.50% | 17.41% |
| Total Finance Division Other Current Liabilities | 18,946.73% | -98.06% | 76.27% | -- | -- |
| Total Other Current Liabilities | 18,946.73% | -98.06% | 76.27% | -- | -- |
| Total Current Liabilities | 84.53% | 58.78% | 33.13% | -16.09% | 25.30% |
|
|
|||||
| Total Current Liabilities | 84.53% | 58.78% | 33.13% | -16.09% | 25.30% |
| Long-Term Debt | 0.02% | 0.02% | 0.02% | 0.02% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -7.01% | -6.05% | -4.79% | -4.49% | -4.22% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -97.36% | 3.87% | 6.85% | 20.87% | 2.41% |
| Total Liabilities | 8.21% | 14.02% | 7.38% | -0.03% | 168.25% |
|
|
|||||
| Common Stock & APIC | -9.09% | 30.83% | 1.75% | 4.46% | 5.59% |
| Retained Earnings | 9.13% | 5.19% | -0.95% | -9.68% | -14.13% |
| Treasury Stock & Other | 15.28% | 323.53% | -62.39% | -37.40% | -59.66% |
| Total Common Equity | -9.03% | 106.05% | 3.39% | -5.24% | -7.40% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -9.03% | 106.05% | 3.39% | -5.24% | -7.40% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -9.03% | 106.05% | 3.39% | -5.24% | -7.40% |
|
|
|||||